Vis enkel innførsel

dc.contributor.authorElsaid, Khaled
dc.contributor.authorMerriman, Tony R.
dc.contributor.authorRossitto, Leigh-Ana
dc.contributor.authorLiu-Bryan, Ru
dc.contributor.authorKarsh, Jacob
dc.contributor.authorPhipps-Green, Amanda
dc.contributor.authorJay, Gregory D.
dc.contributor.authorElsayed, Sandy
dc.contributor.authorQadri, Marwa
dc.contributor.authorMiner, Marin
dc.contributor.authorCadzow, Murray
dc.contributor.authorDambruoso, Talia J.
dc.contributor.authorSchmidt, Tannin A.
dc.contributor.authorDalbeth, Nicola
dc.contributor.authorChhana, Ashika
dc.contributor.authorHöglund, Jennifer
dc.contributor.authorGhassemian, Majid
dc.contributor.authorCampeau, Anaamika
dc.contributor.authorMaltez, Nancy
dc.contributor.authorKarlsson, Niclas
dc.contributor.authorGonzalez, David J.
dc.contributor.authorTerkeltaub, Robert
dc.date.accessioned2024-02-23T07:23:25Z
dc.date.available2024-02-23T07:23:25Z
dc.date.created2024-01-22T16:03:28Z
dc.date.issued2023
dc.identifier.citationArthritis & Rheumatology. 2023, 75 (5), 794-805.en_US
dc.identifier.issn2326-5191
dc.identifier.urihttps://hdl.handle.net/11250/3119497
dc.description.abstractObjective. In gout, hyperuricemia promotes urate crystal deposition, which stimulates the NLRP3 inflammasome and interleukin-1β (IL-1β)–mediated arthritis. Incident gout without background hyperuricemia is rarely reported. To identify hyperuricemia-independent mechanisms driving gout incidence and progression, we characterized erosive urate crystalline inflammatory arthritis in a young female patient with normouricemia diagnosed as having sufficient and weighted classification criteria for gout according to the American College of Rheumatology (ACR)/EULAR gout classification criteria (the proband). Methods. We conducted whole-genome sequencing, quantitative proteomics, whole-blood RNA-sequencing analysis using serum samples from the proband. We used a mouse model of IL-1β–induced knee synovitis to charac- terize proband candidate genes, biomarkers, and pathogenic mechanisms of gout. Results. Lubricin level was attenuated in human proband serum and associated with elevated acute-phase reac- tants and inflammatory whole-blood transcripts and transcriptional pathways. The proband had predicted damaging gene variants of NLRP3 and of inter-α trypsin inhibitor heavy chain 3, an inhibitor of lubricin-degrading cathepsin G. Changes in the proband’s serum protein interactome network supported enhanced lubricin degradation, with cathepsin G activity increased relative to its inhibitors, SERPINB6 and thrombospondin 1. Activation of Toll-like recep- tor 2 (TLR-2) suppressed levels of lubricin mRNA and lubricin release in cultured human synovial fibroblasts (P < 0.01). Lubricin blunted urate crystal precipitation and IL-1β induction of xanthine oxidase and urate in cultured macrophages (P < 0.001). In lubricin-deficient mice, injection of IL-1β in knees increased xanthine oxidase–positive synovial resident M1 macrophages (P < 0.05). Conclusion. Our findings linked normouricemic erosive gout to attenuated lubricin, with impaired control of cathepsin G activity, compounded by deleterious NLRP3 variants. Lubricin suppressed monosodium urate crystalliza- tion and blunted IL-1β–induced increases in xanthine oxidase and urate in macrophages. The collective activities of articular lubricin that could limit incident and erosive gouty arthritis independently of hyperuricemia are subject to dis- ruption by inflammation, activated cathepsin G, and synovial fibroblast TLR-2 signaling.en_US
dc.language.isoengen_US
dc.rightsCC BY-NC-ND 4.0 DEED Attribution-NonCommercial-NoDerivs 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleAmplification of Inflammation by Lubricin Deficiency Implicated in Incident, Erosive Gout Independent of Hyperuricemiaen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.doi10.1002/art.42413
dc.identifier.cristin2232228
dc.source.journalArthritis & Rheumatologyen_US
dc.source.volume75en_US
dc.source.issue5en_US
dc.source.pagenumber794-805en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

CC BY-NC-ND 4.0 DEED
Attribution-NonCommercial-NoDerivs 4.0 International
Med mindre annet er angitt, så er denne innførselen lisensiert som CC BY-NC-ND 4.0 DEED Attribution-NonCommercial-NoDerivs 4.0 International